Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Andrew D. Mosholder"'
Autor:
Gregory E Simon, Susan M Shortreed, Jennifer M Boggs, Gregory N Clarke, Rebecca C Rossom, Julie E Richards, Arne Beck, Brian K Ahmedani, Karen J Coleman, Bhumi Bhakta, Christine C Stewart, Stacy Sterling, Michael Schoenbaum, R Yates Coley, Marc Stone, Andrew D Mosholder, Zimri S Yaseen
Publikováno v:
Journal of the American Medical Informatics Association. 29:2023-2031
Objective Assess the accuracy of ICD-10-CM coding of self-harm injuries and poisonings to identify self-harm events. Materials and Methods In 7 integrated health systems, records data identified patients reporting frequent suicidal ideation. Records
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a89eb09f466c1975698bf0a9e531f31
https://doi.org/10.1093/jamia/ocac144
https://doi.org/10.1093/jamia/ocac144
Publikováno v:
Journal of Psychiatric Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6945c3ef09f1a0792b5050f0ac54f68b
https://doi.org/10.1016/j.jpsychires.2023.05.076
https://doi.org/10.1016/j.jpsychires.2023.05.076
Publikováno v:
Neurological Sciences
There is growing concern that multiple sclerosis (MS) patients on certain therapies may be at higher risk for severe coronavirus disease 2019 (COVID-19). We conducted a systematic literature review to examine the available data on U.S. therapies appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155ccf7789a246b506cb9396ee183b97
https://doi.org/10.1007/s10072-021-05846-3
https://doi.org/10.1007/s10072-021-05846-3
Autor:
Andrew D. Mosholder, Justin Bohn, Jennifer G. Lyons, Richard S. Swain, Dinci Pennap, Sarah K. Dutcher, Emily C. Welch
Publikováno v:
Journal of Affective Disorders. 296:635-641
Background Recent suggestions of therapeutic inequivalence of brand and generic sertraline have raised concerns about disproportionately higher adverse events among generic users. Objective To assess the impact of confounding in a comparison of the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ced7b0c18e86bc3dc53931e9b82fec8
https://doi.org/10.1016/j.jad.2021.09.088
https://doi.org/10.1016/j.jad.2021.09.088
Autor:
Andrew D. Mosholder, Yong Ma, Sandia Akhtar, Gerald D. Podskalny, Yuhui Feng, Hai Lyu, Jiemin Liao, Yuqin Wei, Michael Wernecke, Kira Leishear, Lorene M. Nelson, Thomas E. MaCurdy, Jeffrey A. Kelman, David J. Graham
Publikováno v:
The American journal of psychiatry. 179(8)
Pimavanserin, a serotonin 5-HTThis was a retrospective new-user cohort study of Medicare beneficiaries with Parkinson's disease initiating pimavanserin (N=3,227) or atypical antipsychotics (N=18,442) from April 2016 to March 2019. All-cause mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25de2db9c8f5be33cf72619d31d278a6
https://pubmed.ncbi.nlm.nih.gov/35702829
https://pubmed.ncbi.nlm.nih.gov/35702829
Autor:
Lockwood G. Taylor, Elisa R Braver, Andrew D. Mosholder, Richard S. Swain, Wei Liu, Simone P. Pinheiro
Publikováno v:
International Journal of Epidemiology. 48:1636-1649
Background Suicidal outcomes, including ideation, attempt, and completed suicide, are an important drug safety issue, though few epidemiological studies address the accuracy of suicidal outcome ascertainment. Our primary objective was to evaluate val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e83f2a95460bdc36f4007313711b16
https://doi.org/10.1093/ije/dyz038
https://doi.org/10.1093/ije/dyz038
Autor:
Pamala A. Pawloski, Robert Ball, Sengwee Toh, Jea Young Min, Margaret A. Adgent, Laura Shockro, Ryan M. Carnahan, Katelyn J. King, Andrew D. Mosholder, Denise M. Boudreau, Jennifer L. Kuntz, Sarah K. Dutcher, Andrew B. Petrone, Wei Hua, Charles E. Leonard, Jessica G. Young, Candace C. Fuller, Cheryl N. McMahill-Walraven, Ingrid A. Binswanger, Robert Rosofsky, Marie R. Griffin
Publikováno v:
JMIR Research Protocols
JMIR Research Protocols, Vol 9, Iss 11, p e21811 (2020)
JMIR Research Protocols, Vol 9, Iss 11, p e21811 (2020)
Background Certain medications may increase the risk of death or death from specific causes (eg, sudden cardiac death), but these risks may not be identified in premarket randomized trials. Having the capacity to examine death in postmarket safety su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799c2ae3c97a6109a547b1ae69706303
http://europepmc.org/articles/PMC7669437
http://europepmc.org/articles/PMC7669437
Autor:
Sengwee Toh, Efe Eworuke, Dinci Pennap, Noelle M. Cocoros, Andrew D. Mosholder, Elizabeth C. Dee, Veronica V. Sansing-Foster, Ella Pestine, Nicole Haug, Andrew B. Petrone, Ivone Kim, Yong Ma, Jennifer G. Lyons, Marie C. Bradley
Publikováno v:
The journal of allergy and clinical immunology. In practice. 9(1)
Background There have been conflicting results from observational studies regarding the risk of psychiatric adverse events (PAEs) with montelukast use. Objective To determine whether there are associations of depressive disorders, self-harm, and suic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864b3da1d3b4130a4facdda47c52a37d
https://pubmed.ncbi.nlm.nih.gov/32795564
https://pubmed.ncbi.nlm.nih.gov/32795564
Publikováno v:
The Journal of Clinical Psychiatry. 80
Objective To evaluate stroke risk among users of typical antipsychotics compared to users of atypical antipsychotics in a non-elderly and non-demented US population. Methods New users of antipsychotics aged 18-64 years without dementia were identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6870eda78e5d2d617a0f9c78269b803
https://doi.org/10.4088/jcp.18m12636
https://doi.org/10.4088/jcp.18m12636
Autor:
Kwan Hur, XiangMing Wei, Rongping Zhang, Andrew D. Mosholder, Sherrie L. Aspinall, Chester B. Good, Donald R. Miller, Madeline McCarren, Diane Dong, Francesca E. Cunningham, David J. Graham
Publikováno v:
Addiction. 111:1283-1292
Aims We compared the risk of mental health episodes requiring hospitalization (primary aim) or out-patient clinic visits (secondary aim) associated with varenicline versus the nicotine patch (NP) in an era prior to psychiatric boxed warnings. Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e56fcd1842f65b4407518a9c5e335f28
https://doi.org/10.1111/add.13329
https://doi.org/10.1111/add.13329